Notice: Passwords are now case-sensitive
Forgot your password? Register a new account

Connections

Groups

Community Requests

Oct 30 - Nov 1 Comp Laude® Awards and Gala Manchester Grand Hyatt San Diego
Register Now!

FDA Meeting to Focus on Abuse-Deterrent Opioids

Friday, June 23, 2017 | 421 | 0 | 0 min read

The U.S. Food and Drug Administration will host a public workshop on July 10-11 to discuss methods for evaluating the impacts of abuse-deterrent opioids. According to an issues paper prepared for the meeting, determining the real-world impact of abuse-deterrent opioid formulations is a key step in understanding whether the products can help curb the opioid abuse epidemic. Product-specific exposure can be difficult to determine because it often occurs outside the health care system in individuals who have not been prescribed the drugs, FDA said. The meeting will take place each day from 8:30 ...

Purchase this story for only $9.16!Add to Cart


For access to all of our articles, check out our subscription options.

Comments

Be the first to comment.

Related Articles